Starlight Cardiovascular

Starlight Cardiovascular is a private, pre-revenue medical device startup founded in 2019 and headquartered in San Carlos, California. The company is developing a specialized portfolio of interventional and surgical devices tailored to the unique anatomy and physiology of neonates and infants with congenital heart defects. With a seasoned leadership team combining deep clinical, engineering, and commercial expertise, and strong ties to Boston Children's Hospital, Starlight is positioned to tackle a significant market opportunity in pediatric cardiology where innovation has lagged behind adult care.

Application of advanced medical device engineering, miniaturization, and specialized materials science (notably Nitinol expertise) to develop devices specifically for pediatric cardiovascular anatomy and physiology.

The pediatric CHD device space is relatively uncrowded, as major medtech firms often prioritize larger adult markets. Competition may come from a few specialized pediatric-focused startups and off-label use of adapted adult devices. Starlight's differentiation is its dedicated design-from-the-ground-up approach and deep clinical collaboration.